Dr. Reddy’s Laboratories has unveiled sapropterine dihydrochloride powder for oral solution, 100 mg, Kuvanne (sapropterine dihydrochloride) powder for oral solution in the USA, 100 mg, USP
Indicated for the treatment of phenylketonuria, it has been initiated after approval from the US Food and Drug Administration. (USFDA). CEO (North America Generics) Mark Kikuchi said the company is committed to bringing affordable generic medicines. In addition, “this product shows that we are actively increasing the breadth of our portfolio with the treatment of a rare disease,” he said. The product is available in a 30-count carton in a 100-mg unit dose packet, the release said.
Leave a Reply